Skip to main content
. 2018 Aug 14;59(10):1951–1966. doi: 10.1194/jlr.P080218

TABLE 2.

Results of the statistical association tests from the discovery, replication, and meta-analysis phases with TG (P approaching genome-wide significance at ≤6.12E-09) when modeled for the recessive mode of inheritance

SNP: Effect Allele Gene: Functional Consequences Phase Effect Sizea a Effect Sizeb b Effect Sizec c Effect Sized d
rs1002487: C RPS6KA1: intron Discovery 3.337 7.17E-11 3.344 6.69E-11 3.402 1.91E-11 3.202 3.32E-10
Replication 1.036 0.01805 1.045 0.0165 1.062 0.01508 1.029 0.01765
Meta 6.517 7.17E-11 6.197 5.76E-10 6.532 6.49E-11 6.18 6.42E-10
rs11805972: T LAD1: P > Q Discovery 2.481 8.55E-11 2.48 8.79E-11 2.467 7.12E-11 2.404 2.54E-10
Replication 1.893 4.03E-08 1.878 4.50E-08 1.861 6.26E-08 1.835 7.98E-08
Meta 8.485 2.16E-17 8.351 6.75E-17 8.451 2.89E-17 8.281 1.23E-16
rs7761746: A OR5V1: synonymous Discovery 2.447 1.89E-09 2.443 2.08E-09 2.37 4.31E-09 2.49 7.36E-10
Replication 0.8277 9.97E-03 0.8443 7.88E-03 0.7594 1.62E-02 0.8576 6.44E-03
Meta 6.066 1.31E-09 6.229 4.68E-10 5.85 4.91E-09 6.277 3.45E-10
rs39745: T CTTNBP2, LSM8: intergenic Discovery 1.485 3.63E-09 1.486 3.56E-09 1.427 1.09E-08 1.473 3.76E-09
Replication 0.4809 3.69E-02 0.4769 3.95E-02 0.5116 0.02603 0.5255 0.0221
Meta 5.643 1.67E-08 5.619 1.92E-08 5.613 1.99E-08 5.782 7.39E-09
rs2934952: G PGAP3: intron Discovery 0.773 3.17E-09 0.7722 3.38E-09 0.7527 5.95E-09 0.7617 4.21E-09
Replication 0.3243 6.87E-03 0.3167 7.94E-03 0.2927 1.35E-02 0.3152 7.66E-03
Meta 6.086 1.16E-09 6.054 1.41E-09 5.859 4.67E-09 6.03 1.64E-09
rs9626773: A RP11-191L9.4, CERK: intergenic Discovery 2.848 1.42E-09 2.857 1.29E-09 2.751 3.65E-09 2.93 3.56E-10
Replication 3.395 8.60E-07 3.315 1.54E-06 3.368 9.85E-07 3.313 1.26E-06
Meta 7.776 7.47E-15 7.855 4.00E-15 7.647 2.06E-14 7.882 3.21E-15

Effect size represents β value for the discovery and replication phases and Z-score for meta-analysis.

a

Regular correction: corrected for age, sex, and the top 10 principal components that resulted from the PCA of the genotype data.

b

Corrected for lipid medication in addition to the regular correction.

c

Corrected for obesity (using BMI as the characterizing trait) in addition to the regular correction.

d

Corrected for diabetes status in addition to the regular correction.